CNTG vs. ATNFW, SXTPW, ACONW, AIMDW, DRTSW, ALVOW, AONCW, AONC, APLMW, and ARTLW
Should you be buying Centogene stock or one of its competitors? The main competitors of Centogene include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Aclarion (ACONW), Ainos (AIMDW), Alpha Tau Medical (DRTSW), Alvotech (ALVOW), American Oncology Network (AONCW), American Oncology Network (AONC), Apollomics (APLMW), and Artelo Biosciences (ARTLW). These companies are all part of the "medical" sector.
Centogene (NASDAQ:CNTG) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, earnings, community ranking, media sentiment, profitability, valuation and dividends.
Centogene received 40 more outperform votes than 180 Life Sciences when rated by MarketBeat users.
9.9% of Centogene shares are held by institutional investors. 1.9% of Centogene shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
In the previous week, Centogene had 2 more articles in the media than 180 Life Sciences. MarketBeat recorded 3 mentions for Centogene and 1 mentions for 180 Life Sciences. Centogene's average media sentiment score of 0.28 beat 180 Life Sciences' score of 0.00 indicating that Centogene is being referred to more favorably in the media.
180 Life Sciences has lower revenue, but higher earnings than Centogene.
Summary
Centogene beats 180 Life Sciences on 6 of the 6 factors compared between the two stocks.
Get Centogene News Delivered to You Automatically
Sign up to receive the latest news and ratings for CNTG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CNTG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Centogene Competitors List
Related Companies and Tools
